Breaking News Instant updates and real-time market news.

2022-07-05 09:03:39 MNST Monster Beverage $94.59 / +1.955 (+2.11%) 09:03 07/05/22 07/05 09:03 07/05/22 09:03	Monster Beverage initiated with a Neutral at Roth Capital Roth Capital analyst Sean McGowan initiated coverage of Monster Beverage with a Neutral rating and $100 price target. Monster has about a 34% share of the U.S. energy drink market and is the world's largest energy drink maker, behind only Red Bull, noted McGowan. Though Monster has been "a stellar performer over the past 20 years," he believes the stock's current valuation is fair relative to the company's growth prospects, McGowan tells investors.

2022-07-05 09:03:39

MNST

Monster Beverage

$94.59 / +1.955 (+2.11%)

09:03

07/05/22

07/05

09:03

07/05/22

09:03

Monster Beverage initiated with a Neutral at Roth Capital

Roth Capital analyst Sean McGowan initiated coverage of Monster Beverage with a Neutral rating and $100 price target. Monster has about a 34% share of the U.S. energy drink market and is the world's largest energy drink maker, behind only Red Bull, noted McGowan. Though Monster has been "a stellar performer over the past 20 years," he believes the stock's current valuation is fair relative to the company's growth prospects, McGowan tells investors.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Save Foods initiates seven commercial pilots with Peruvian exporters » 08:40 08/12/22 08/12 08:40 08/12/22 08:40 SVFD Save Foods $5.85 / +0.41 (+7.54%) Save Foods announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News SVFD Save Foods $5.85 / +0.41 (+7.54%) 08/08/22 Save Foods completes pilot programs with lime packers in Mexico 08/05/22 Save Foods Inc trading resumes 08/05/22 Save Foods Inc trading halted, volatility trading pause 07/28/22 Save Foods prepares for cirtus season in Turkey
Downgrade	Monness Crespi downgrades PagerDuty, expects recent strength to 'fizzle out' » 08:40 08/12/22 08/12 08:40 08/12/22 08:40 PD PagerDuty $28.13 / -1.145 (-3.91%) Monness Crespi analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PD PagerDuty $28.13 / -1.145 (-3.91%) 06/29/22 PagerDuty CEO sells $2.11M in common stock 05/24/22 PagerDuty expands international presence to Japan 05/02/22 PagerDuty appoints Katherine Post Calvert as CMO 03/17/22 PagerDuty rises 15.3% PD PagerDuty $28.13 / -1.145 (-3.91%) 07:31 Today Monness Crespi PagerDuty downgraded to Neutral from Buy at Monness Crespi 07/07/22 Canaccord PagerDuty initiated with a Buy at Canaccord 06/03/22 Craig-Hallum PagerDuty price target lowered to $37 from $45 at Craig-Hallum 06/03/22 Baird PagerDuty price target lowered to $40 from $47 at Baird PD PagerDuty $28.13 / -1.145 (-3.91%) 06/02/22 PagerDuty sees FY23 EPS (21c)-(17c), consensus (20c) 06/02/22 PagerDuty sees Q2 EPS (9c)-(8c), consensus (8c) 06/02/22 PagerDuty reports Q1 EPS (4c), consensus (8c) 03/16/22 PagerDuty sees FY23 adjusted EPS (23c)-(17c), consensus (19c) PD PagerDuty $28.13 / -1.145 (-3.91%) 06/02/22 Fly Intel: After-Hours Movers 03/17/22 What You Missed On Wall Street On Thursday 03/17/22 What You Missed On Wall Street This Morning 03/16/22 Fly Intel: After-Hours Movers 09/01/22 PagerDuty - PD PD PagerDuty $28.13 / -1.145 (-3.91%) 06/02/22 PagerDuty options imply 11.5% move in share price post-earnings 03/16/22 PagerDuty options imply 16.4% move in share price post-earnings
Hot Stocks	MVB Financial to acquire Integrated Financial in an all-stock transaction » 08:40 08/12/22 08/12 08:40 08/12/22 08:40 MVBF MVB Financial $34.56 / +0.7 (+2.07%) MVB Financial announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MVBF MVB Financial $34.56 / +0.7 (+2.07%) 03/14/22 MVB Financial announces 38% interest in Warp Speed Holdings for $48M MVBF MVB Financial $34.56 / +0.7 (+2.07%) 04/01/22 Raymond James MVB Financial initiated with a Strong Buy at Raymond James MVBF MVB Financial $34.56 / +0.7 (+2.07%) 08/01/22 MVB Financial reports Q2 EPS 23c, consensus 33c 05/02/22 MVB Financial reports Q1 EPS 22c, consensus 35c 02/17/22 MVB Financial reports Q4 EPS 77c, consensus 30c 08/23/22 Online Gaming Conference
Earnings	1847 Holdings reports Q2 revenue $12.9M vs. $6.6M last year » 08:39 08/12/22 08/12 08:39 08/12/22 08:39 EFSH 1847 Holdings $3.80 / -0.06 (-1.55%) "I would like to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings EFSH 1847 Holdings $3.80 / -0.06 (-1.55%) 08/02/22 1847 Holdings extends pricing of public offering of common shares 07/29/22 1847 Holdings files registration statement for public offering of shares 07/28/22 1847 Holdings announces expected $5.4M debt reduction 07/19/22 1847 Holdings announces approval to uplist to NYSE American Exchange EFSH 1847 Holdings $3.80 / -0.06 (-1.55%) 05/19/22 1847 Holdings reports Q1 revenue $12.1M vs. $4.8M last year
Syndicate	Certara 7M share Spot Secondary priced at $17.75 » 08:38 08/12/22 08/12 08:38 08/12/22 08:38 CERT Certara $20.16 / -0.19 (-0.93%) The deal range was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly CERT Certara $20.16 / -0.19 (-0.93%) 08/05/22 Certara announces release 5.2.0 of Pinnacle 21 Enterprise 07/28/22 Certara enters collaboration with Memorial Sloan Kettering Cancer Center 07/25/22 Certara appoints Crane as new independent board member 07/13/22 Certara appoints Eran Broshy to board of directors CERT Certara $20.16 / -0.19 (-0.93%) 08/10/22 Piper Sandler Certara price target lowered to $25 from $28 at Piper Sandler 07/15/22 SVB Securities Certara initiated with an Outperform at SVB Securities (earlier) 07/13/22 Barclays Certara price target lowered to $24 from $25 at Barclays 07/01/22 Piper Sandler Certara initiated with an Overweight at Piper Sandler CERT Certara $20.16 / -0.19 (-0.93%) 08/09/22 Certara cuts FY22 EPS view to 43c-48c from 48c-53c, consensus 50c 08/09/22 Certara reports Q2 adjusted EPS 9c, consensus 11c 05/05/22 Certara reiterates FY22 adjusted EPS view 48c-53c, consensus 44c 05/05/22 Certara reports Q1 adjusted EPS 11c, consensus 9c 12 Aug 18 Nov 09 Sep CERT Certara $20.16 / -0.19 (-0.93%) 08/11/22 Fly Intel: After-Hours Movers
Hot Stocks	Palisade Bio prices $12M upsized underwritten public offering » 08:38 08/12/22 08/12 08:38 08/12/22 08:38 PALI Palisade Bio / + Palisade Bio announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PALI Palisade Bio / + 08/01/22 Palisade Bio launches new corporate website 07/27/22 Palisade Bio announces first patient screened in Phase 2 study on LB1148 06/29/22 Palisade Bio initiates Phase 3 study of LB1148 05/13/22 Palisade Bio announces expected upcoming milestones PALI Palisade Bio / + 02/02/22 Ladenburg Palisade Bio initiated with a Buy at Ladenburg 08/31/21 Maxim Palisade Bio initiated with a Buy at Maxim 08/31/21 Maxim Palisade Bio initiated with a Buy at Maxim PALI Palisade Bio / + 05/13/22 Palisade Bio reports Q1 EPS (26c) vs ($1.45) last year 03/18/22 Palisade Bio reports 2021 EPS ($3.39) vs ($3.72) last year
Hot Stocks	Ecoark Holdings provides update to investors on recent transactions » 08:38 08/12/22 08/12 08:38 08/12/22 08:38 ZEST Ecoark Holdings $1.97 / -0.01 (-0.51%) Ecoark announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News On The Fly Events ZEST Ecoark Holdings $1.97 / -0.01 (-0.51%) 06/09/22 BitNile investing $12M in Ecoark Holdings 03/10/22 Ecoark Holdings, Zest Labs' lawsuit against Deloitte moves forward 03/09/22 Ecoark's Banner Midstream completes the drilling of Louisiana oil well ZEST Ecoark Holdings $1.97 / -0.01 (-0.51%) 06/10/22 Here's What You Missed in Crypto This Week 09/09/22 Ecoark Holdings, Inc.
Hot Stocks	Biofrontera Inc. expects cash to fund operations for at least next 12 months » 08:37 08/12/22 08/12 08:37 08/12/22 08:37 BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) As of June 30, 2022,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08/01/22 Biofrontera announces patent in Australia for novel illumination protocols 07/27/22 Biofrontera Inc. announces exercise of existing warrants 07/12/22 Biofrontera Inc. sees Q2 product revenue $4.4M-$4.6M 05/16/22 Biofrontera Inc. announces pricing of $9.4M private placement BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 12/30/21 Benchmark Biofrontera AG financial reporting may now change, says Benchmark 12/15/21 Benchmark Biofrontera initiated with a Buy at Benchmark 11/24/21 Roth Capital Roth Capital bullish on Biofrontera, initiates with a Buy 11/24/21 Roth Capital Biofrontera initiated with a Buy at Roth Capital BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08:35 Today Biofrontera Inc. expects 2022 revenue up at least 30% vs. 2021 08:35 Today Biofrontera Inc. reports Q2 EPS (5c) vs. (46c) last year 05/13/22 Biofrontera Inc. reaffirms FY22 revenue view up at least 30% vs 2021 05/13/22 Biofrontera Inc. reports Q1 EPS 32c vs (44c) last year 29 Oct BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 04/08/22 Fly Intel: Pre-market Movers 11:00 Today Biofrontera Inc. - BFRI BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 05/11/22 Eighteen new option listings on May 11th
Earnings	BTCS reports Q2 EPS (61c) vs (89c) last year » 08:36 08/12/22 08/12 08:36 08/12/22 08:36 BTCS BTCS $1.75 / -0.09 (-4.89%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BTCS BTCS $1.75 / -0.09 (-4.89%) 07/05/22 BTCS appoints Adele Carey as VP, investor relations 05/17/22 BTCS to join panel discussing cryptocurrency hosted by FORCE Family Office 05/11/22 BTCS adds Axie Infinity to blockchain infrastructure operations 04/27/22 BTCS adds Kava to its blockchain infrastructure operations BTCS BTCS $1.75 / -0.09 (-4.89%) 03/28/22 H.C. Wainwright BTCS initiated with a Buy at H.C. Wainwright BTCS BTCS $1.75 / -0.09 (-4.89%) 05/16/22 BTCS reports Q1 EPS (47c) vs ($2.43) last year 03/14/22 BTCS reports 2021 EPS ($3.09) vs. (86c) last year
Earnings	Biofrontera Inc. expects 2022 revenue up at least 30% vs. 2021 » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) Biofrontera Inc. affirms… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08/01/22 Biofrontera announces patent in Australia for novel illumination protocols 07/27/22 Biofrontera Inc. announces exercise of existing warrants 07/12/22 Biofrontera Inc. sees Q2 product revenue $4.4M-$4.6M 05/16/22 Biofrontera Inc. announces pricing of $9.4M private placement BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 12/30/21 Benchmark Biofrontera AG financial reporting may now change, says Benchmark 12/15/21 Benchmark Biofrontera initiated with a Buy at Benchmark 11/24/21 Roth Capital Roth Capital bullish on Biofrontera, initiates with a Buy 11/24/21 Roth Capital Biofrontera initiated with a Buy at Roth Capital BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08:35 Today Biofrontera Inc. reports Q2 EPS (5c) vs. (46c) last year 05/13/22 Biofrontera Inc. reaffirms FY22 revenue view up at least 30% vs 2021 05/13/22 Biofrontera Inc. reports Q1 EPS 32c vs (44c) last year 04/08/22 Biofrontera Inc. sees 2022 revenue up 30% vs. 2021 29 Oct BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 04/08/22 Fly Intel: Pre-market Movers 11:00 Today Biofrontera Inc. - BFRI BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 05/11/22 Eighteen new option listings on May 11th

Earnings	PhaseBio reports Q2 EPS (34c) vs. (60c) » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 PHAS PhaseBio $1.19 / +0.05 (+4.39%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PHAS PhaseBio $1.19 / +0.05 (+4.39%) 05/16/22 PhaseBio announces successful Pre-BLA meeting with U.S. FDA for bentracimab 04/04/22 PhaseBio: primary reversal endpoint in achieved bentracimab Phase 2b trial 03/08/22 PhaseBio completes bentracimab PPQ campaign PHAS PhaseBio $1.19 / +0.05 (+4.39%) 10/13/21 Stifel PhaseBio resumed with a Buy at Stifel PHAS PhaseBio $1.19 / +0.05 (+4.39%) 05/16/22 PhaseBio reports Q1 EPS (23c), consensus (66c) 03/24/22 PhaseBio reports Q4 EPS (90c), consensus (59c) PHAS PhaseBio $1.19 / +0.05 (+4.39%) 05/16/22 Fly Intel: Pre-market Movers
Earnings	Biofrontera Inc. reports Q2 EPS (5c) vs. (46c) last year » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) Reports Q2 revenue $4.5M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08/01/22 Biofrontera announces patent in Australia for novel illumination protocols 07/27/22 Biofrontera Inc. announces exercise of existing warrants 07/12/22 Biofrontera Inc. sees Q2 product revenue $4.4M-$4.6M 05/16/22 Biofrontera Inc. announces pricing of $9.4M private placement BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 12/30/21 Benchmark Biofrontera AG financial reporting may now change, says Benchmark 12/15/21 Benchmark Biofrontera initiated with a Buy at Benchmark 11/24/21 Roth Capital Roth Capital bullish on Biofrontera, initiates with a Buy 11/24/21 Roth Capital Biofrontera initiated with a Buy at Roth Capital BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 05/13/22 Biofrontera Inc. reaffirms FY22 revenue view up at least 30% vs 2021 05/13/22 Biofrontera Inc. reports Q1 EPS 32c vs (44c) last year 04/08/22 Biofrontera Inc. sees 2022 revenue up 30% vs. 2021 04/08/22 Biofrontera Inc. reports Q4 EPS ($1.29) vs. ($2.12) last year 29 Oct BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 04/08/22 Fly Intel: Pre-market Movers 11:00 Today Biofrontera Inc. - BFRI BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 05/11/22 Eighteen new option listings on May 11th
Earnings	Point Biopharma reports Q2 EPS (27c), consensus (22c) » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 PNT Point Biopharma $8.09 / -0.91 (-10.11%) "We continue to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PNT Point Biopharma $8.09 / -0.91 (-10.11%) 08/08/22 Point Biopharma to host investor education event on August 18 06/21/22 Point Biopharma appoints Horvath as EVP, Commercial 05/16/22 Point Biopharma unveils FRONTIER: pan-cancer clinical program 05/13/22 Point Biopharma sees cash, equivalents funding operations into 1Q24 PNT Point Biopharma $8.09 / -0.91 (-10.11%) 07/06/22 William Blair William Blair starts Point Biopharma at Outperform on 'superior' manufacturing 07/06/22 William Blair Point Biopharma initiated with an Outperform at William Blair 05/26/22 Jefferies Point Biopharma assumed with Buy from Hold at Jefferies 05/13/22 Piper Sandler Point Biopharma price target lowered to $14 from $17 at Piper Sandler PNT Point Biopharma $8.09 / -0.91 (-10.11%) 05/13/22 Point Biopharma reports Q1 EPS (18c), consensus (21c) 03/25/22 Point Biopharma reports Q4 EPS (16c), consensus (23c)
General news	July export prices down 3.3% vs. last month, consensus 0.1% 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
General news	July export prices up 13.1% vs. last year 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
General news	July import prices up 8.8% vs. last year, consensus 9.4% 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Downgrade	Mister Car Wash downgraded to Equal Weight from Overweight at Morgan Stanley » 08:34 08/12/22 08/12 08:34 08/12/22 08:34 MCW Mister Car Wash $12.00 / -0.25 (-2.04%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 08/03/22 Mister Car Wash acquires Top Wash in Minnesota 06/27/22 Mister Car Wash falls -5.3% 04/29/22 Mister Car Wash acquires Speedwash, terms undisclosed 03/24/22 Mister Car Wash jumps over 3% to $16.39 after Q4 earnings beat MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 06/27/22 Goldman Sachs Mister Car Wash downgraded to Sell from Neutral at Goldman Sachs 05/13/22 BMO Capital Mister Car Wash price target lowered to $18 from $23 at BMO Capital 05/13/22 Piper Sandler Mister Car Wash price target lowered to $13 from $18 at Piper Sandler 03/25/22 BMO Capital Mister Car Wash price target lowered to $23 from $25 at BMO Capital MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 08/11/22 Mister Car Wash cuts FY22 EPS view to 36c-39c from 44c-47c, consensus 45c 08/11/22 Mister Car Wash reports Q2 adjusted EPS 11c, consensus 12c 05/12/22 Mister Car Wash backs FY22 EPS view of 44c-47c, consensus 46c 05/12/22 Mister Car Wash reports Q1 EPS 11c, consensus 11c 24 Aug MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 08/11/22 Fly Intel: After-Hours Movers 05/13/22 What You Missed On Wall Street On Friday 05/13/22 What You Missed On Wall Street This Morning 03/25/22 What You Missed On Wall Street On Friday
General news	July import prices down 1.4% vs. last month, consensus down 0.9% 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Hot Stocks	Acer Therapeutics, Relief receive orphan drug designation for ACER-001 » 08:33 08/12/22 08/12 08:33 08/12/22 08:33 ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) , RLFTF Relief / + RELIEF THERAPEUTICS… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ACER RLFTF ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) 07/28/22 Relief, Acer announce submit IND application to FDA for ACER-001 in MSUD 07/28/22 Relief, Acer announce FDA acceptance of review for ACER-001 NDA resubmission 07/18/22 Acer Therapeutics resubmits NDA for ACER-001 for treatment of UCDs 07/08/22 Acer, Relief announces utility model patent issuance for ACER-001 by CNIPA RLFTF Relief / + 07/28/22 Relief, Acer announce submit IND application to FDA for ACER-001 in MSUD 07/28/22 Relief, Acer announce FDA acceptance of review for ACER-001 NDA resubmission 07/08/22 Acer, Relief announces utility model patent issuance for ACER-001 by CNIPA 06/21/22 Acer Therapeutics, Relief announce update on FDA review of NDA for ACER-001 ACER RLFTF ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) 01/11/22 H.C. Wainwright Acer Therapeutics assumed with a Buy at H.C. Wainwright 10/06/21 William Blair Acer Therapeutics set up for 'major event' with NDA accepted, says William Blair RLFTF Relief / + 10/06/21 William Blair Acer Therapeutics set up for 'major event' with NDA accepted, says William Blair ACER ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) 03/02/22 Acer Therapeutics reports Q4 EPS (31c), consensus (1c) 01/15/23 PDUFA Date for ACER-001
Hot Stocks	AGBA Acquisition extends consummation period for business combination » 08:33 08/12/22 08/12 08:33 08/12/22 08:33 AGBA AGBA Acquisition $11.37 / + (+0.00%) AGBA Acquisition… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Downgrade	TerrAscend downgraded to Hold from Buy at Craig-Hallum » 08:32 08/12/22 08/12 08:32 08/12/22 08:32 TRSSF TerrAscend $2.40 / +0.11 (+4.80%) Craig-Hallum analyst Eric… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 06/02/22 TerrAscend debuts Cookies, Gage brands in New Jersey 03/09/22 TerrAscend to close Gage Growth acquisition on March 10 TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 07:30 Today Cantor Fitzgerald TerrAscend downgraded to Neutral from Overweight at Cantor Fitzgerald 07/22/22 Seaport Global TerrAscend initiated with a Buy at Seaport Global 02/09/22 Clarus TerrAscend price target lowered to C$14 from C$16.25 at Clarus 12/08/21 Cantor Fitzgerald TerrAscend price target raised to $7.65 from $6.70 at Cantor Fitzgerald TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 04/14/22 Here's What You Missed in Cannabis This Week
Recommendations	State Street price target raised to $74 from $67 at Deutsche Bank » 08:30 08/12/22 08/12 08:30 08/12/22 08:30 STT State Street $73.51 / +1 (+1.38%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options STT State Street $73.51 / +1 (+1.38%) 07/21/22 State Street appoints Brenda Tsai as global chief marketing officer 07/15/22 State Street raises FY22 NII view to up 24%-27% from up 18%-20% 07/15/22 State Street sees Q3 NII up 5%-9% 07/15/22 State Street says raising prices across services STT State Street $73.51 / +1 (+1.38%) 07/18/22 Deutsche Bank State Street price target raised to $67 from $65 at Deutsche Bank 07/13/22 Deutsche Bank State Street price target lowered to $65 from $67 at Deutsche Bank 07/12/22 Citi State Street price target lowered to $69 from $93 at Citi 07/11/22 UBS State Street price target lowered to $91 from $101 at UBS STT State Street $73.51 / +1 (+1.38%) 07/15/22 State Street reports Q2 ex-items EPS $1.94 vs. $1.57 last year 07/14/22 Notable companies reporting before tomorrow's open 04/14/22 State Street reports Q1 adjusted EPS $1.59, consensus $1.47 04/13/22 Notable companies reporting before tomorrow's open 10 Sep STT State Street $73.51 / +1 (+1.38%) 06/09/22 State Street tells Bloomberg not pursuing any deal with Credit Suisse 06/09/22 State Street says not pursuing any deal with Credit Suisse, Bloomberg reports 06/09/22 Credit Suisse CEO says State Street buyout questions 'really stupid' 06/08/22 State Street tells Bloomberg not responding to Credit Suisse report STT State Street $73.51 / +1 (+1.38%) 07/15/22 What You Missed On Wall Street On Friday 07/15/22 What You Missed On Wall Street This Morning 06/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/09/22 What You Missed On Wall Street On Thursday STT State Street $73.51 / +1 (+1.38%) 07/15/22 Early notable gainers among liquid option names on July 15th
Recommendations	Invesco price target raised to $20 from $18 at Deutsche Bank » 08:30 08/12/22 08/12 08:30 08/12/22 08:30 IVZ Invesco $18.49 / +0.2925 (+1.61%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly IVZ Invesco $18.49 / +0.2925 (+1.61%) 08/09/22 Invesco reports preliminary AUM $1.45T as of July 31 07/12/22 Invesco reports preliminary AUM $1.39T as of June 30 07/07/22 Invesco Real Estate Income acquires two self-storage portfolios for $42M 06/09/22 Invesco reports AUM of $1.4516B as of May 31, 2022 IVZ Invesco $18.49 / +0.2925 (+1.61%) 07/18/22 JPMorgan Invesco price target lowered to $20 from $22 at JPMorgan 07/13/22 Deutsche Bank Invesco price target lowered to $19 from $21 at Deutsche Bank 07/11/22 UBS Invesco price target lowered to $21 from $27 at UBS 06/28/22 Keefe Bruyette Invesco price target lowered to $18 from $21 at Keefe Bruyette IVZ Invesco $18.49 / +0.2925 (+1.61%) 07/27/22 Invesco reports Q2 adjusted EPS 39c vs. 67c last year 06/20/22 Fly Intel: Top five weekend stock stories 04/26/22 Invesco reports Q1 adjusted EPS 56c, consensus 58c IVZ Invesco $18.49 / +0.2925 (+1.61%) 06/18/22 BlackRock, T. Rowe Price worth a look, Barron's says 05/18/22 GOP looks to curb voting power of BlackRock, other asset managers, WSJ reports IVZ Invesco $18.49 / +0.2925 (+1.61%) 06/13/22 What You Missed On Wall Street On Monday 06/13/22 Fly Intel: Pre-market Movers
Options	One new option listing and one option delisting on August 12th » 08:30 08/12/22 08/12 08:30 08/12/22 08:30 SLAC Social Leverage Acquisition Corp I $9.86 / + (+0.00%) , SYNL Synalloy / + New option listings for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings SLAC SLAC Social Leverage Acquisition Corp I $9.86 / + (+0.00%) 08/01/22 W3BCLOUD to become public through Social Leverage Acquisition Corp I combination SYNL SYNL Synalloy / + 08/09/22 Synalloy reports Q2 EPS $1.06 vs. 31c last year 05/10/22 Synalloy reports Q1 EPS 99c vs. 12c last year
Recommendations	Robinhood price target raised to $10 from $9 at Deutsche Bank » 08:29 08/12/22 08/12 08:29 08/12/22 08:29 HOOD Robinhood $10.51 / -0.08 (-0.76%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/08/22 Robinhood exec sells $1.18M in common stock 08/04/22 Robinhood CEO says in 'great position as a stand-alone company' 08/04/22 SEC probing Robinhood compliance with short selling rules 08/02/22 Robinhood sees FY22 operating expenses $1.7B-$1.76B HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/04/22 Deutsche Bank Robinhood price target raised to $9 from $8 at Deutsche Bank 08/04/22 Mizuho Robinhood price target lowered to $13 from $14 at Mizuho 08/03/22 Piper Sandler Robinhood price target lowered to $10 from $11 at Piper Sandler 07/25/22 JPMorgan JPMorgan sees increased share dilution risk for Coinbase, Robinhood HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/03/22 Notable companies reporting after market close 08/02/22 Robinhood reports Q2 EPS (34c), consensus (37c) 04/28/22 Robinhood reports Q1 EPS (45c), consensus (36c) 04/28/22 Notable companies reporting after market close HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/11/22 Judge rules Robinhood must face market manipulation claims, Reuters says 07/20/22 Study finds Robinhood cause of phantom surge in Berkshire Hathaway, WSJ reports 06/27/22 Bankman-Fried says FTX not in active M&A talks with Robinhood, WSJ says 06/27/22 FTX deliberating about potential of deal to buy Robinhood, Bloomberg says HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/11/22 What You Missed On Wall Street On Thursday 08/05/22 Here's What You Missed in Crypto This Week 08/03/22 Fly Intel: After-Hours Movers 08/03/22 What You Missed On Wall Street On Wednesday HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/08/22 Robinhood Markets call volume above normal and directionally bullish 08/05/22 Unusually active option classes on open August 5th 08/04/22 Robinhood Markets call volume above normal and directionally bullish 08/04/22 Unusually active option classes on open August 4th

Events

Earnings calls, analyst events, roadshows and more

IMH
Today at 09:00

IMPAC Mortgage - IMH Conference Calls
ICCC
Today at 09:00

Immucell - ICCC Conference Calls
BWMN
Today at 09:00

Bowman Consulting - BWMN Conference Calls
SPB
Today at 09:00

Spectrum Brands - SPB Conference Calls
VET
Today at 09:00

Vermilion Energy - VET Conference Calls
SIDU
Today at 09:00

Sidus Space - SIDU Conference Calls
Today at 10:00

Consumer Sentiment Index: August (p) 2022 Government Event
STRR
Today at 10:00

Star Equity - STRR Conference Calls
BKYI
Today at 10:00

BIO-key - BKYI Conference Calls
PAM
Today at 10:00

Pampa Energia - PAM Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies Priced at: $215.00 3.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MIRM X MIRM Mirum Pharmaceuticals Spot Secondary Managers: JPMorgan, SVB Securities & Evercore ISI, Raymond James Priced at: $23.00 3.48M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TDW X TDW Tidewater Spot Secondary Managers: Morgan Stanley Priced at: $17.85 3.52M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ATNX X ATNX Athenex Secondary Managers: SVB Securities Priced at: $.75 35.3M Shares CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler Priced at: $30.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVTC X EVTC Evertec Secondary Managers: JPMorgan Priced at: $32.00 6.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXU X LXU LSB Industries Secondary Managers: Goldman Sachs & UBS, Deutsche Bank, Jefferies, Piper Sandler, RBC Capital, BNP Paribas, Stifel Priced at: $13.00 13.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital Priced at: $14.00 8.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRNA X VRNA Verona Pharma Secondary Managers: Jefferies, Piper Sandler & Truist Priced at: $10.50 12.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNL X BNL Broadstone Net Lease Spot Secondary Managers: Goldman Sachs, BMO Capital, JPMorgan & Truist Priced at: $21.35 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Sandler & Stifel Priced at: $55.00 750K Shares MAIN X MAIN Main Street Spot Secondary Managers: RBC Capital, UBS & Wells Fargo Priced at: $42.85 1.17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity Priced at: $5.00 3M Shares REBN X REBN Reborn Coffee IPO Managers: EF Hutton Priced at: $5.00 1.44M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TGL X TGL Treasure Global IPO Managers: EF Hutton Priced at: $4.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CERE X CERE Cerevel Therapeutics Secondary Managers: Morgan Stanley, Goldman Sachs, Jefferies & Evercore ISI, Loop Capital, Seibert Williams Priced at: $35.00 7.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INAB X INAB In8bio Secondary Managers: H.C. Wainwright Priced at: $1.90 5.39M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler Priced at: $23.75 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CERT X CERT Certara Spot Secondary Managers: Morgan Stanley Priced at: $17.75 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INSP X INSP Inspire Medical Spot Secondary Managers: Goldman Sachs Priced at: $215.00 1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	BIAF X BIAF Bioaffinity Technologies IPO Managers: WallachBeth $6.00-6.25 1.285M Shares
Wed	No deals
Thurs	RANI X RANI Rani Therapeutics Secondary Managers: BofA, Cantor Fitzgerald & UBS, BTIG, H.C. Wainwright $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Monster Beverage initiated with a Neutral at Roth Capital

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access